Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 May 2;2(2):e000172.
doi: 10.1136/esmoopen-2017-000172. eCollection 2017.

Multiple primary tumours: challenges and approaches, a review

Affiliations
Review

Multiple primary tumours: challenges and approaches, a review

Alexia Vogt et al. ESMO Open. .

Abstract

When in a patient more than one tumour in the same or a different organ is diagnosed, multiple primary tumours may be present. For epidemiological studies, different definitions of multiple primaries are used with the two main definitions coming from the project Surveillance Epidemiology and End Results and the International Association of Cancer Registries and International Agency for Research on Cancer. The differences in the two definitions have to be taken into consideration when reports on multiple primaries are analysed. In this review, the literature on multiple primaries is reviewed and summarised. Overall, the frequency of multiple primaries is reported in the range of 2-17%. Aetiological factors that may predispose patients to multiple primaries can be grouped into host related, lifestyle factors and environmental influences. Some of the most common cancer predisposition syndromes based on a clinical presentation are discussed and the relevant genetic evaluation and testing are characterised. Importantly, from a clinical standpoint, clinical situations when multiple primaries should be suspected and ruled out in a patient are discussed. Furthermore, general principles and possible treatment strategies for patients with synchronous and metachronous multiple primary tumours are highlighted.

Keywords: Multiple primary cancer; epidemiology; genetic predisposition; multiple primaries; second cancer; secondary primary.

PubMed Disclaimer

Conflict of interest statement

Competing interests: AO: advisory role (compensated, institutional): Astellas, Bayer, Sanofi, Roche, Janssen. Research support (institutional): Teva, Janssen. Travel support: Astellas, Bayer, Sanofi, Roche. SS: advisory role (compensated institutional): Böhringer Ingelheim, BMS. AV, KH, HF, CH and TC report no competing interests.

Similar articles

Cited by

References

    1. American Cancer Society. Cancer facts & figures 2016. 2016 Atlanta: American Cancer Society, 2016.
    1. Herrmann C, Cerny T, Savidan A, et al. . Cancer survivors in Switzerland: a rapidly growing population to care for. BMC Cancer 2013;13:287.10.1186/1471-2407-13-287 - DOI - PMC - PubMed
    1. Owen LJ. Multiple malignant neoplasms. JAMA 1921;76:1329–33.
    1. Coyte A, Morrison DS, McLoone P. Second primary cancer risk - the impact of applying different definitions of multiple primaries: results from a retrospective population-based cancer registry study. BMC Cancer 2014;14:272.10.1186/1471-2407-14-272 - DOI - PMC - PubMed
    1. Buiatti E, Crocetti E, Acciai S, et al. . Incidence of second primary cancers in three Italian population-based cancer registries. Eur J Cancer 1997;33:1829–34.10.1016/S0959-8049(97)00173-1 - DOI - PubMed